| Not Yet Recruiting | Tumor-Lymph Node Mapping NCT07054944 | University of Rochester | Phase 1 |
| Recruiting | Maintenance Zanzalintinib With Etoposide After HDCT in GCT NCT06937866 | Indiana University | Phase 1 / Phase 2 |
| Recruiting | A Study of ZW251 in Participants With Advanced Solid Tumors NCT07164313 | Zymeworks BC Inc. | Phase 1 |
| Recruiting | A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced G NCT06866964 | Wake Forest University Health Sciences | Phase 2 |
| Recruiting | Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With NCT07188441 | Chengcheng Guo | Phase 2 |
| Not Yet Recruiting | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage So NCT06363201 | Catalysis SL | N/A |
| Not Yet Recruiting | SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours NCT06329323 | Imperial College London | — |
| Recruiting | Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors NCT06276491 | Xencor, Inc. | Phase 1 |
| Recruiting | High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors NCT06418789 | N.N. Petrov National Medical Research Center of Oncology | Phase 2 |
| Recruiting | Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors NCT05874063 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Recruiting | Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer NCT06133543 | Heinrich-Heine University, Duesseldorf | N/A |
| Recruiting | Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose NCT05889585 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Recruiting | Molecular Epidemiology of Pediatric Germ Cell Tumors NCT05564026 | Children's Oncology Group | — |
| Recruiting | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-N NCT05259605 | European Organisation for Research and Treatment of Cancer - EORTC | — |
| Recruiting | Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043 | Beijing Tiantan Hospital | — |
| Completed | CD30 CAR for CD30+ NSGCT NCT05634785 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Withdrawn | A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors NCT04791228 | Children's National Research Institute | Phase 2 |
| Recruiting | Multidisciplinary Approach to Fatigue NCT05502224 | Jules Bordet Institute | N/A |
| Terminated | A Study of DS-9606a in Patients With Advanced Solid Tumors NCT05394675 | Daiichi Sankyo | Phase 1 |
| Completed | Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor NCT06470464 | Shandong First Medical University | Phase 2 |
| Active Not Recruiting | A Phase II Trial of Cabozantinib With Patients With Refractory GCTs NCT04876456 | Jennifer King | Phase 2 |
| Recruiting | Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT NCT04804007 | Nabil Adra | Phase 2 |
| Unknown | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Childre NCT05179850 | West China Hospital | — |
| Active Not Recruiting | A Study of miRNA 371 in Patients With Germ Cell Tumors NCT04435756 | SWOG Cancer Research Network | — |
| Active Not Recruiting | B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT04483778 | Seattle Children's Hospital | Phase 1 |
| Completed | Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children NCT06341998 | Shandong First Medical University | Phase 2 / Phase 3 |
| Completed | Symptom Management for YA Cancer Survivors NCT04035447 | Duke University | N/A |
| Recruiting | Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Mid NCT04185038 | Seattle Children's Hospital | Phase 1 |
| Active Not Recruiting | EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT03618381 | Seattle Children's Hospital | Phase 1 |
| Completed | Disulfiram and Cisplatin in Refractory TGCTs. NCT03950830 | National Cancer Institute, Slovakia | Phase 2 |
| Completed | EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS NCT03638167 | Seattle Children's Hospital | Phase 1 |
| Unknown | Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cel NCT03868176 | Centre Hospitalier Universitaire de Besancon | — |
| Active Not Recruiting | HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumor NCT03500991 | Seattle Children's Hospital | Phase 1 |
| Unknown | Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) NCT03476070 | National University of Singapore | — |
| Active Not Recruiting | Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy NCT03418844 | Centre Francois Baclesse | N/A |
| Withdrawn | Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy NCT03960151 | Costantine Albany | Phase 2 |
| Completed | Role of Axumin PET Scan in Germ Cell Tumor NCT03426865 | University of Texas Southwestern Medical Center | — |
| Completed | Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy f NCT03194906 | St. Jude Children's Research Hospital | Phase 2 |
| Recruiting | Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients W NCT03067181 | Children's Oncology Group | Phase 3 |
| Active Not Recruiting | Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors NCT03158064 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors NCT02988843 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Recruiting | Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330 | New York Medical College | Phase 1 |
| Terminated | Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors NCT03081923 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Terminated | Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) NCT02624388 | University of Virginia | Phase 2 |
| Active Not Recruiting | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treat NCT02375204 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumo NCT02429466 | Nasser Hanna | Phase 1 |
| Completed | First Line TIP in Poor Prognosis TGCTs. NCT02414685 | National Cancer Institute, Slovakia | Phase 2 |
| Completed | A Pilot RCT of the PRISM Intervention for AYAs With Cancer NCT02340884 | Seattle Children's Hospital | Phase 2 |
| Completed | MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors NCT02076906 | AeRang Kim | Phase 1 |
| Recruiting | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tu NCT02582697 | University of Sydney | Phase 3 |
| Recruiting | Germ Cell Tumor and Testicular Tumor DNA Registry NCT02099734 | Memorial Sloan Kettering Cancer Center | — |
| Completed | A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory S NCT01625351 | St. Jude Children's Research Hospital | Phase 1 |
| Unknown | Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors NCT01966913 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Recruiting | Establishing Prospective Mediastinal Tumor Database of PUMCH NCT06421805 | Peking Union Medical College Hospital | — |
| Completed | Everolimus in Refractory Testicular Germ Cell Cancer NCT01466231 | National Cancer Institute, Slovakia | Phase 2 |
| Completed | Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors NCT01331135 | Emory University | Phase 1 |
| Active Not Recruiting | Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors NCT01049230 | Massachusetts General Hospital | N/A |
| Unknown | Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CN NCT00983398 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Completed | Collecting and Storing Tissue From Young Patients With Cancer NCT00898755 | Children's Oncology Group | — |
| Unknown | Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors NCT00127049 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Terminated | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant NCT00369291 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Terminated | Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors NCT00198172 | Indiana University School of Medicine | Phase 2 |
| Unknown | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors NCT00179816 | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 1 / Phase 2 |